The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: A systematic review

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Gillies, Michelle ^a   Palmateer, Norah ^b   Hutchinson, Sharon ^b,c   Ahmed, Syed ^d   Taylor, Avril ^e   Goldberg, David ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^e UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TRANSMISSION; FEMALE; HEPATITIS C; HUMAN; MALE; MICROBIOLOGY; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; REVIEW; SUBSTANCE ABUSE;

FEMALE; HEPATITIS C; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; PRIMARY PREVENTION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 78549236194     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-721     Document Type: Article

References (35)

1. Sharing of drug preparation equipment as a risk factor for hepatitis C. H Hagan H Thiede NS Weiss, et al. Am J Public Health 2001 91 42 46 10.2105/AJPH.91.9.1350 11189822
2. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. JA Hahn K Page-Shafer PJ Lum, et al. J Infect Dis 2002 186 1558 1564 10.1086/345554 12447730
3. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. LE Thorpe LJ Ouellet, Am J Epidemiol 2002 155 645 653 10.1093/aje/155.7.645 11914192
4. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. K Roy G Hay R Andragetti A Taylor D Goldberg L Wiessing, Epidemiol Infect 2002 129 3 577 585 10.1017/ S0950268802007902 12558341
5. Risk factors for hepatitis C transmission to healthcare workers after occupational exposure: a European case-control study. Y Yazdanpanah G De Carli B Migueres, et al. Clin Infect Dis 2005 41 1423 1430 10.1086/497131 16231252
6. Guidance for clinical healthcare workers: protection against infection with bloodborne viruses. Expert Advisory Group on AIDS and the Advisory Group on Hepatitis, London: UK Health Departments 1998
7. Examining the Injecting practices of injecting drug users in Scotland. A Taylor A Fleming J Rutherford D Goldberg, Scottish executive Interventions Unit 2004 http://www.drugmisuse.isdscotland.org/eiu/pubs/eiu-060.htm
8. HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. RH Needle S Coyle H Cesari, et al. Subst Use Misuse 1998 33 12 2403 2423 10.3109/10826089809059332 9781822
9. Drug sharing among heroin networks: Implications for HIV and Hepatitis B and C prevention. S Koester J Glanz A Baron, AIDS and Behavior 2005 9 1 27 39 10.1007/s10461-005-1679-y 15812611
10. Joint drug purchases and drug preparation risk behaviors among Puerto Rican injection drug users. HM Colon HA Finlinson RR Robles, et al. AIDS and Behavior 2001 5 1 85 96 10.1023/A:1009515723223 (Pubitemid 35364159)
11. Minimising harm from hepatitis c virus needs better strategies. N Crofts C Caruana S Bowden M Kerger, BMJ 2000 321 7265 899 10.1136/bmj.321.7265.899 11021890
12. Giving away used injection equipment: missed prevention message? C Strike DZ Buchman RC Callaghan, et al. Harm Reduction Journal 2010 7 2 10.1186/1477-7517-7-2 20181128
13. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. P De E Roy JF Boivin J Cox C Morissette, J Viral Hepat 2008 15 279 292 10.1111/j.1365-2893.2007.00942.x 18208496
14. The NTA's 2005 survey of needle exchange in England. London: National Treatment Agency. D Abdulrahim D Gordon D Best, 2008
15. Needle exchange provision in Scotland: a report of the national needle exchange survey. D Griesbach D Abdulrahim D Gordon K Dowell, Edinburgh. Scottish Executive 2006
16. Needle and syringe programmes: providing people who inject drugs with injecting equipment. National Institute for Health and Clinical Excellence (NICE), Public health guidance 2009 http://www.nice.org.uk/nicemedia/live/12130/ 43301/43301.pdf
17. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. E von Elm DG Altman M Egger SJ Pocock PC Gøtzsche JP Vandenbroucke STROBE Initiative, J Clin Epidemiol 2008 61 4 344 349 10.1016/j.jclinepi.2007.11.008 18313558 (Pubitemid 351289042)
18. Safety, risks and outcomes from the use of injecting paraphernalia. J Scott, Effective Interventions Unit: Edinburgh 2007 http://www.scotland.gov.uk/ Publications/2008/03/14133736/3 2003
19. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. H Hagan H Thiede, J Urban Health 2000 77 3 369 382 10.1007/BF02386747 10976611
20. Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study. D Huo LJ Ouellet, J Acquir Immune Defic Syndr 2007 45 1 108 114 10.1097/QAI.0b013e318050d260 17460474
21. A cohort study of syringe exchangers and nonexhcangers in San Francisco. C Sears E Weltzien J Guydish, J Drug Issues 2001 31 2 445 464
22. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Stoltz E Wood W Small, et al. J Public Health 2007 29 1 35 39 10.1093/pubmed/fdl090
23. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. D Vlahov B Junge R Brookmeyer, et al. J Acquir Immune Defic Syndr Hum Retrovirol 1997 16 5 400 406 9420320
24. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. RN Bluthenthal AH Kral EA Erringer BR Edlin, J Acquir Immune Defic Syndr Hum Retrovirol 1998 18 5 505 511 9715848
25. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: Implications for HIV and hepatitis C prevention. C Morissette J Cox P De, et al. Int J Drug Policy 2007 18 204 212 10.1016/j.drugpo.2006.08.004 17689367
26. Needle exchange program attendance and injection risk in Providence, Rhode Island. D Longshore RN Bluthenthal MD Stein, AIDS Education and Prevention 2001 13 78 90 10.1521/aeap.13.1.78.18922 11252456
27. Drug-injecting street youth: A comparison of HIV-risk injection behaviors between needle exchange users and nonusers. MD Kipke JB Unger R Palmer R Edgington, AIDS and behaviour 1997 1 4 225 232 10.1023/A:1026275301883
28. Investigation of a secondary syringe exchange programme for homeless young adult injection drug users in San Fransisco, California, U.S.A. C Sears JR Guydish EK Weltzien, et al. J Acquir Immune Defic Syndr 2001 27 2 193 201 11404542
29. Hepatitis-assoicated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. R Heimer S Clair LE Grau, et al. Addiction 2002 97 1277 1287 10.1046/j.1360-0443.2002.t01-1-00211.x 12359032
30. Evaluating needle exchange: A description of client characteristics, health status, program utilization, and HIV risk behavior. J Guydish J Bucardo G Clark S Bernheim, Subst Use Misuse 1998 33 5 1173 1196 10.3109/ 10826089809062213 9596382
31. Pilot trial of an intervention aimed at modifying drug preparation practices among injection drug users in Puerto Rico. HM Colon HA Finlinson J Negron, et al. AIDS Behav 2009 13 523 531 10.1007/s10461-009-9540-3 19308722
32. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. S Darke W Hall N Weather J Ward A Wodak, AIDS 1991 5 181 185 10.1097/00002030-199102000-00008 2031690
33. Injecting equipment schemes for injecting drug users qualitative evidence review. National Institute for Health and Clinical Excellence (NICE), 2008 http://www.nice.org.uk/nicemedia/live/11829/41923/41923.pdf
34. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. VD Hope M Hickman SL Ngui, et al. J Viral Hepat 2010 20456636
35. Acute hepatitis C virus infection. WL Irving D Salmon C Boucher IM Hoepelman, Eurosurveill 2008 13 21 pii=18879